Neothramycin

Last updated
Neothramycin A and B Neothramycin A and B.png
Neothramycin A and B

Neothramycin A and B are stereoisomeric antibiotics with anticancer activity. The stereoisomers are interchangeable in aqueous solution and the antibiotic, Neothramycin, contains both in approximately equal amounts. [1] They belong to the pyrrolo(1,4)benzodiazepine, or anthramycin, group which includes other antibiotics such as anthramycin, tomaymycin, and sibiromycin. Neothramycin was originally isolated from Streptomyces No. MC916-C4, a cycloheximide-producing strain, by Umezawa et al. [2] Subsequent testing has shown its capabilities as an anticancer drug, antiprotozoal drug, and even possible uses in DNA fluorescence based assays. [3] Its activities against cancer warranted phase I testing of the drug. [4] More recently, in 1991, anthramycin derivatives, which are very similar to neothramycin, have been investigated for their ability to link DNA when dimerized. These compounds were tested using a fluorescence based assay. These compounds showed an ability to bind dG-containing DNA duplexes with high specificity. This specificity of a DNA crosslinking agent is highly sought after since most are electrophiles and bind indiscriminately. The data collected also showed that pyrrolo(1,4)benzodiazepines can also be used to measure the fluorescence polarization anisotropy on the 0.1-100 ns time scale. [5]

Contents

Activity

Neothramycin shows weak antimicrobial activity compared to other pyrrolo(1,4)benzodiazepines. It also shows lower toxicity in mice. Neothramycin has been shown to exhibit activity against Yoshida sarcoma in rats, leukemia P388, sarcoma 180, Ehrlich Ascites carcinoma, Walker carcinosarcoma-256, and light activity against leukemia L-1210 in mice. [6] These activities against cancer are typical to the activities seen in the other pyrrolo(1,4)benzodiazepine compounds. Neothramycin has also been tested, alongside other compounds, against malaria and for antiprotozoal activity. It showed moderate activity towards malaria with an IC50 value of about 1 μg/mL. Neothramycin also showed high cytotoxicity towards MRC-5 cells with and IC50 of 390 ng/mL. Butylneothramycin A, a derivative of neothramycin, showed 6-7 fold lower antiprotozoal activity than neothramycin. [7]

Mechanism

Neothramycin’s mode of action is widely known to be through the inhibition of DNA-dependent RNA and DNA polymerase. [7] The antibiotic activity of neothramycin was determined to be directly binding DNA by UV-Vis absorption measurements with differing concentrations of DNA and neothramycin. [8] The first studies of neothramycin began thinking that DNA was the chemoreceptor due to the inhibition of DNA and RNA polymerase that they observed when neothramycin was added. [9] The antibiotic activity, since these first studies, has been determined to be due to its direct binding of DNA. More specifically, the neothramycin binds the NH2 of guanine in the minor groove. This binding was shown to only occur when the DNA is in duplex. [10] This type of binding is observed in the other pyrrolo(1,4)benzodiazepines as well. However, the binding of neothramycin to DNA is much slower than the other compounds in the group. This binding of neothramycin to DNA does not significantly change the melting temperature of the DNA.

Clinical Testing

Neothramycin went through phase I testing between June 1979 and June 1981. They determined the maximum tolerable dose to be 60 mg/m2 per single injection. Approximately half of the patients experienced nausea and vomiting, the most severe toxicity observed. Some hepatotoxic and nephrotoxic effects were observed but were reversible. The phase I clinical trial determined that 30–40 mg/m2 would be the optimal dose for phase II. [11]

Related Research Articles

Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small fragments of nucleic acids can be manufactured as single-stranded molecules with any user-specified sequence, and so are vital for artificial gene synthesis, polymerase chain reaction (PCR), DNA sequencing, molecular cloning and as molecular probes. In nature, oligonucleotides are usually found as small RNA molecules that function in the regulation of gene expression, or are degradation intermediates derived from the breakdown of larger nucleic acid molecules.

DNA topoisomerases are enzymes that catalyze changes in the topological state of DNA, interconverting relaxed and supercoiled forms, linked (catenated) and unlinked species, and knotted and unknotted DNA. Topological issues in DNA arise due to the intertwined nature of its double-helical structure, which, for example, can lead to overwinding of the DNA duplex during DNA replication and transcription. If left unchanged, this torsion would eventually stop the DNA or RNA polymerases involved in these processes from continuing along the DNA helix. A second topological challenge results from the linking or tangling of DNA during replication. Left unresolved, links between replicated DNA will impede cell division. The DNA topoisomerases prevent and correct these types of topological problems. They do this by binding to DNA and cutting the sugar-phosphate backbone of either one or both of the DNA strands. This transient break allows the DNA to be untangled or unwound, and, at the end of these processes, the DNA backbone is resealed. Since the overall chemical composition and connectivity of the DNA do not change, the DNA substrate and product are chemical isomers, differing only in their topology.

<span class="mw-page-title-main">Helicase</span> Class of enzymes to unpack an organisms genes

Helicases are a class of enzymes thought to be vital to all organisms. Their main function is to unpack an organism's genetic material. Helicases are motor proteins that move directionally along a nucleic acid phosphodiester backbone, separating two hybridized nucleic acid strands, using energy from ATP hydrolysis. There are many helicases, representing the great variety of processes in which strand separation must be catalyzed. Approximately 1% of eukaryotic genes code for helicases.

DNA gyrase, or simply gyrase, is an enzyme within the class of topoisomerase and is a subclass of Type II topoisomerases that reduces topological strain in an ATP dependent manner while double-stranded DNA is being unwound by elongating RNA-polymerase or by helicase in front of the progressing replication fork. It is the only known enzyme to actively contribute negative supercoiling to DNA, while it also is capable of relaxing positive supercoils. It does so by looping the template to form a crossing, then cutting one of the double helices and passing the other through it before releasing the break, changing the linking number by two in each enzymatic step. This process occurs in bacteria, whose single circular DNA is cut by DNA gyrase and the two ends are then twisted around each other to form supercoils. Gyrase is also found in eukaryotic plastids: it has been found in the apicoplast of the malarial parasite Plasmodium falciparum and in chloroplasts of several plants. Bacterial DNA gyrase is the target of many antibiotics, including nalidixic acid, novobiocin, albicidin, and ciprofloxacin.

<span class="mw-page-title-main">Hoechst stain</span> Fluorescent dye used to stain DNA

Hoechst stains are part of a family of blue fluorescent dyes used to stain DNA. These bis-benzimides were originally developed by Hoechst AG, which numbered all their compounds so that the dye Hoechst 33342 is the 33,342nd compound made by the company. There are three related Hoechst stains: Hoechst 33258, Hoechst 33342, and Hoechst 34580. The dyes Hoechst 33258 and Hoechst 33342 are the ones most commonly used and they have similar excitation–emission spectra.

<span class="mw-page-title-main">Calicheamicin</span> Chemical compound

The calicheamicins are a class of enediyne antitumor antibiotics derived from the bacterium Micromonospora echinospora, with calicheamicin γ1 being the most notable. It was isolated originally in the mid-1980s from the chalky soil, or "caliche pits", located in Kerrville, Texas. The sample was collected by a scientist working for Lederle Labs. It is extremely toxic to all cells and, in 2000, a CD33 antigen-targeted immunoconjugate N-acetyl dimethyl hydrazide calicheamicin was developed and marketed as targeted therapy against the non-solid tumor cancer acute myeloid leukemia (AML). A second calicheamicin-linked monoclonal antibody, inotuzumab ozogamicin, an anti-CD22-directed antibody-drug conjugate, was approved by the U.S. Food and Drug Administration on August 17, 2017, for use in the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. Calicheamicin γ1 and the related enediyne esperamicin are the two of the most potent antitumor agents known.

<span class="mw-page-title-main">Rebeccamycin</span> Chemical compound

Rebeccamycin (NSC 655649) is a weak topoisomerase I inhibitor isolated from Nocardia sp. It is structurally similar to staurosporine, but does not show any inhibitory activity against protein kinases. It shows significant antitumor properties in vitro (IC50=480nM against mouse B16 melanoma cells and IC50=500nM against P388 leukemia cells). It is an antineoplastic antibiotic and an intercalating agent.

<span class="mw-page-title-main">Pixantrone</span> Chemical compound

Pixantrone is an experimental antineoplastic (anti-cancer) drug, an analogue of mitoxantrone with fewer toxic effects on cardiac tissue. It acts as a topoisomerase II poison and intercalating agent. The code name BBR 2778 refers to pixantrone dimaleate, the actual substance commonly used in clinical trials.

<span class="mw-page-title-main">Nucleic acid analogue</span> Compound analogous to naturally occurring RNA and DNA

Nucleic acid analogues are compounds which are analogous to naturally occurring RNA and DNA, used in medicine and in molecular biology research. Nucleic acids are chains of nucleotides, which are composed of three parts: a phosphate backbone, a pentose sugar, either ribose or deoxyribose, and one of four nucleobases. An analogue may have any of these altered. Typically the analogue nucleobases confer, among other things, different base pairing and base stacking properties. Examples include universal bases, which can pair with all four canonical bases, and phosphate-sugar backbone analogues such as PNA, which affect the properties of the chain . Nucleic acid analogues are also called xeno nucleic acids and represent one of the main pillars of xenobiology, the design of new-to-nature forms of life based on alternative biochemistries.

Antimicrobial pharmacodynamics is the relationship between the concentration of an antibiotic and its ability to inhibit vital processes of endo- or ectoparasites and microbial organisms. This branch of pharmacodynamics relates the concentration of an anti-infective agent to its effect, specifically to its antimicrobial effect.

<span class="mw-page-title-main">Macbecin</span> Chemical compound

Macbecins are a pair of chemical compounds in the ansamycin family of antibiotics. They are designated macbecin I and macbecin II and they were first isolated from actinomycete bacteria. Macbecin possesses antitumor properties. In vitro studies have shown that macbecins are effective in the eradication of Gram-positive bacteria, fungi, and protozoa including Tetrahymena pyriformis.

<span class="mw-page-title-main">Enediyne</span> Any organic compound containing one double and two triple bonds

Enediynes are organic compounds containing two triple bonds and one double bond.

<span class="mw-page-title-main">HU-331</span> Chemical compound

HU-331 is a quinone anticarcinogenic drug synthesized from cannabidiol, a cannabinoid in the Cannabis sativa plant. It showed a great efficacy against oncogenic human cells. HU-331 does not cause arrest in cell cycle, cell apoptosis or caspase activation. HU-331 inhibits DNA topoisomerase II even at nanomolar concentrations, but has shown a negligible effect on the action of DNA topoisomerase I. The cannabinoid quinone HU-331 is a very specific inhibitor of topoisomerase II, compared with most known anticancer quinones. One of the main objectives of these studies is the development of a new quinone derived compound that produces anti-neoplastic activity while maintaining low toxicity at therapeutic doses.

The duocarmycins are members of a series of related natural products first isolated from Streptomyces bacteria in 1978. They are notable for their extreme cytotoxicity and thus represent a class of exceptionally potent antitumour antibiotics.

Free radical damage to DNA can occur as a result of exposure to ionizing radiation or to radiomimetic compounds. Damage to DNA as a result of free radical attack is called indirect DNA damage because the radicals formed can diffuse throughout the body and affect other organs. Malignant melanoma can be caused by indirect DNA damage because it is found in parts of the body not exposed to sunlight. DNA is vulnerable to radical attack because of the very labile hydrogens that can be abstracted and the prevalence of double bonds in the DNA bases that free radicals can easily add to.

<span class="mw-page-title-main">Chartreusin</span> Chemical compound

Chartreusin is an antibiotic originally isolated from the bacteria Streptomyces Chartreusis. The crystalline compound itself has a yellow-green colour, as per its name, and is stable at room temperature for several hours. Chartreusin is chemically related to elsamitrucin, as the two share an aglycone chartarin structure, though they differ in their sugar moieties. Both chartreusin and elsamitrucin were found to have anticancer activity.

<span class="mw-page-title-main">DNA base flipping</span> Biochemical process

DNA base flipping, or nucleotide flipping, is a mechanism in which a single nucleotide base, or nucleobase, is rotated outside the nucleic acid double helix. This occurs when a nucleic acid-processing enzyme needs access to the base to perform work on it, such as its excision for replacement with another base during DNA repair. It was first observed in 1994 using X-ray crystallography in a methyltransferase enzyme catalyzing methylation of a cytosine base in DNA. Since then, it has been shown to be used by different enzymes in many biological processes such as DNA methylation, various DNA repair mechanisms, and DNA replication. It can also occur in RNA double helices or in the DNA:RNA intermediates formed during RNA transcription.

<span class="mw-page-title-main">Ellipticine</span> Chemical compound

Ellipticine is an alkaloid first extracted from trees of the species Ochrosia elliptica and Rauvolfia sandwicensis, which inhibits the enzyme topoisomerase II via intercalative binding to DNA.

<span class="mw-page-title-main">C-1027</span> Chemical compound

C-1027 or lidamycin is an antitumor antibiotic consisting of a complex of an enediyne chromophore and an apoprotein. It shows antibiotic activity against most Gram-positive bacteria. It is one of the most potent cytotoxic molecules known, due to its induction of a higher ratio of DNA double-strand breaks than single-strand breaks.

References

  1. Mechanism of action of neothramycin I. The effect on macromolecular synthesis
  2. Mechanism of action of neothramycin I. The effect on macromolecular synthesis
  3. Farmer, JD Jr; Gustafson, GR; Conti, A; Zimmt, MB; Suggs, JW (1991). "DNA binding properties of a new class of linked anthramycin analogs". Nucleic Acids Res. 19 (4): 899–903. doi:10.1093/nar/19.4.899. PMC   333728 . PMID   1708126.
  4. Phase I study of a new antitumor antibiotic, neothramycin
  5. Farmer, JD Jr; Gustafson, GR; Conti, A; Zimmt, MB; Suggs, JW (1991). "DNA binding properties of a new class of linked anthramycin analogs". Nucleic Acids Res. 19 (4): 899–903. doi:10.1093/nar/19.4.899. PMC   333728 . PMID   1708126.
  6. Antitumor effect of new antibiotic, neothramycin
  7. 1 2 Otoguro, Kazuhiko; Iwatsuki, Masato; Ishiyama, Aki; Namatame, Miyuki; Nishihara-Tukashima, Aki; Shibahara, Seiji; Kondo, Shinichi; Yamada, Haruki; Ōmura, Satoshi (2010). "Promising lead compounds for novel antiprotozoans". The Journal of Antibiotics. 63 (7): 381–384. doi: 10.1038/ja.2010.50 . PMID   20661239. S2CID   7508758.
  8. Mechanism of action of neothramycin II. Interaction with DNA
  9. Mechanism of action of neothramycin I. The effect on macromolecular synthesis
  10. Farmer, JD Jr; Gustafson, GR; Conti, A; Zimmt, MB; Suggs, JW (1991). "DNA binding properties of a new class of linked anthramycin analogs". Nucleic Acids Res. 19 (4): 899–903. doi:10.1093/nar/19.4.899. PMC   333728 . PMID   1708126.
  11. Phase I study of a new antitumor antibiotic, neothramycin